Literature DB >> 25999040

Demographic correlates of attenuated positive psychotic symptoms.

Rachel N Waford1, Allison MacDonald2, Katrina Goines2, Derek M Novacek2, Hanan D Trotman2, Walker Elaine F2, Jean Addington3, Carrie E Bearden4, Kristin S Cadenhead5, Tyrone D Cannon6, Barbara A Cornblatt7, Robert Heinssen8, Daniel H Mathalon9, Ming T Tsuang5, Diana O Perkins10, Larry J Seidman11, Scott W Woods6, Thomas H McGlashan6.   

Abstract

It is now well established that the utilization of standardized clinical criteria can enhance prediction of psychosis. These criteria are primarily concerned with the presence and severity of attenuated positive symptoms. Because these symptom criteria are used to derive algorithms for designating clinical high risk (CHR) status and for maximizing prediction of psychosis risk, it is important to know whether the symptom ratings vary as a function of demographic factors that have previously been linked with symptoms in diagnosed psychotic patients. Using a sample of 356 CHR individuals from the NAPLS-II multi-site study, we examined the relation of three sex, age, and educational level, with the severity of attenuated positive symptom scores from the Scale of Prodromal Symptoms (SOPS). Demographic factors accounted for little of the variance in symptom ratings (5-6%). Older CHR individuals manifested more severe suspiciousness, and female CHR participants reported more unusual perceptual experiences than male participants. Contrary to prediction, higher educational level was associated with more severe ratings of unusual thought content, but less severe perceptual abnormalities. Overall, sex, age and education were modestly related to unusual thought content and perceptual abnormalities, only, suggesting minimal implication for designating CHR status and predicting psychosis-risk.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Early identification; Education; Prodrome; Psychosis; Sex

Mesh:

Year:  2015        PMID: 25999040      PMCID: PMC4767147          DOI: 10.1016/j.schres.2015.04.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'.

Authors:  Oliver Mason; Mike Startup; Sean Halpin; Ulrich Schall; Agatha Conrad; Vaughan Carr
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

Review 2.  The positive-negative distinction in schizophrenia. Review of natural history validators.

Authors:  T H McGlashan; W S Fenton
Journal:  Arch Gen Psychiatry       Date:  1992-01

3.  Gender and schizophrenia: age at onset and sociodemographic attributes.

Authors:  O Gureje
Journal:  Acta Psychiatr Scand       Date:  1991-05       Impact factor: 6.392

4.  Prediction of outcome in schizophrenia.

Authors:  H Jonsson; A K Nyman
Journal:  Acta Psychiatr Scand       Date:  1984-04       Impact factor: 6.392

5.  [Do 1st rank symptoms establish the diagnosis of schizophrenia? On the significance of clinical correlations and the limits of criteria].

Authors:  A Marneros
Journal:  Nervenarzt       Date:  1984-07       Impact factor: 1.214

6.  Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.

Authors:  R P Sharma; J I Javaid; G N Pandey; P G Janicak; J M Davis
Journal:  Biol Psychiatry       Date:  1991-09-01       Impact factor: 13.382

7.  Gender and schizophrenia: implications for understanding the heterogeneity of the illness.

Authors:  J M Goldstein; M T Tsuang; S V Faraone
Journal:  Psychiatry Res       Date:  1989-06       Impact factor: 3.222

8.  Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

Authors:  Barnaby Nelson; Hok Pan Yuen; Stephen J Wood; Ashleigh Lin; Daniela Spiliotacopoulos; Annie Bruxner; Christina Broussard; Magenta Simmons; Debra L Foley; Warrick J Brewer; Shona M Francey; G Paul Amminger; Andrew Thompson; Patrick D McGorry; Alison R Yung
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

9.  Gender and the expression of schizophrenia.

Authors:  J M Goldstein; B G Link
Journal:  J Psychiatr Res       Date:  1988       Impact factor: 4.791

10.  Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up.

Authors:  Stephen F Austin; Ole Mors; Rikke Gry Secher; Carsten R Hjorthøj; Nikolai Albert; Mette Bertelsen; Heidi Jensen; Pia Jeppesen; Lone Petersen; Lasse Randers; Anne Thorup; Merete Nordentoft
Journal:  Schizophr Res       Date:  2013-08-08       Impact factor: 4.939

View more
  4 in total

1.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

2.  Sex differences in auditory verbal hallucinations in early, middle and late adolescence: results from a survey of 17 451 Japanese students aged 12-18 years.

Authors:  Yoko Morokuma; Kaori Endo; Atushi Nishida; Syudo Yamasaki; Shuntaro Ando; Yuko Morimoto; Miharu Nakanishi; Yuji Okazaki; Toshi A Furukawa; Shigeru Morinobu; Shinji Shimodera
Journal:  BMJ Open       Date:  2017-06-01       Impact factor: 2.692

3.  Effects of age and sex on clinical high-risk for psychosis in the community.

Authors:  Frauke Schultze-Lutter; Benno G Schimmelmann; Rahel Flückiger; Chantal Michel
Journal:  World J Psychiatry       Date:  2020-05-19

4.  Factors associated with late-life psychosis in primary care older adults without a diagnosis of dementia.

Authors:  Helen-Maria Vasiliadis; Isabelle Pitrou; Catherine Lamoureux-Lamarche; Sébastien Grenier; Patrick Viet-Quoc Nguyen; Carol Hudon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-07-05       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.